Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-12

Clinical Trial Update: BMS-741672 for Diabetic Neuropathic Pain [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of BMS-741672 for diabetic neuropathic pain has completed, providing the Phase 2 readout for this indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BMS-741672

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Neuropathic Pain | Phase 2 | Status: COMPLETED